IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice.
IL-25 has been implicated in the initiation of type 2 immunity and in the protection against autoimmune inflammatory diseases. Recent studies have identified the novel innate lymphoid type 2 cells (ILC2s) as an IL-25 target cell population. The purpose of this study was to evaluate if IL-25 has any...
Main Authors: | Polyxeni T Mantani, Pontus Dunér, Eva Bengtsson, Ragnar Alm, Irena Ljungcrantz, Ingrid Söderberg, Lena Sundius, Fong To, Jan Nilsson, Harry Björkbacka, Gunilla Nordin Fredrikson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4309452?pdf=render |
Similar Items
-
ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions
by: Polyxeni T. Mantani, et al.
Published: (2019-12-01) -
TAP1-deficiency does not alter atherosclerosis development in Apoe-/- mice.
by: Daniel Kolbus, et al.
Published: (2012-01-01) -
Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.
by: Björn Fagerberg, et al.
Published: (2015-01-01) -
Associations Between Macrophage Colony‐Stimulating Factor and Monocyte Chemotactic Protein 1 in Plasma and First‐Time Coronary Events: A Nested Case–Control Study
by: Alexandru Schiopu, et al.
Published: (2016-09-01) -
Antibodies Against Gonadotropin-Releasing Hormone in Patients with Posterior Laryngitis
by: Hillevi Pendleton, et al.
Published: (2013-01-01)